Leukemia/Lymphoma
RSSArticles
-
Special Feature: Maintaining Board Certification
-
Tamoxifen and Breast Cancer Incidence Among Women with Inherited Mutations in BRCA1 and BRCA2
-
Clinical Staging and Chemoradiation for Early Stage Hodgkin’s Disease
-
Ascites, Neoadjuvant Chemotherapy, and Ovarian Cancer
-
XRT to Prevent Local Breast Cancer Recurrence: A Little More is Better
-
Laporoscopic Surgery for Colorectal Cancer
A European multi-institutional trial compared outcome in terms of three-year disease-free and overall survival for patients with colon cancer who had resection either by laparoscopic approach or laparotomy. -
Risks of Androgen Suppression Therapy for Prostate Cancer: The Importance of Comorbidities
In a post hoc analysis of patients entered on a prostate cancer clinical trial, among those receiving androgen suppression therapy, those with higher levels of comorbidity were more likely to suffer adverse consequences, and this was particularly evident for those who had lower risk for prostate cancer specific mortality. -
Dasatinib for CML Blast Phase after Imatinib Failure
Options for CML blast phase after imatinib failure have been very limited. -
Pulmonary Nodule in Patients with Breast Cancer
Of 34 breast cancer patients with pulmonary nodules and no other evidence for metastatic disease, progression occurred in only 3 (of the 26) whose nodules were < 1 cm in diameter, compared with all 8 in whom the nodules were > 1 cm. -
Pharmacology Watch
Drug combinations for hypertension; tenecteplase for out-of-hospital cardiac arrest; CAM most commonly used for back, neck, and arthritis pain; FDA Actions.